What is Liquid Biopsy?
What is Liquid Biopsy?
A Liquid Biopsy is a revolutionary, non-invasive diagnostic test that detects cancer cells, DNA fragments, or other biomarkers in your bloodstream. At Well Again Diagnostic & Health Care Centre, we offer cutting-edge liquid biopsy tests to provide early detection and monitoring for various cancers, allowing for more precise and personalized treatment plans.
Why Choose a Liquid Biopsy?
✔ Non-Invasive: A simple blood draw, avoiding the need for surgical tissue biopsies.
✔ Early Detection: Detect cancer at its earliest stages, even before symptoms arise.
✔ Personalized Monitoring: Track treatment effectiveness and detect potential recurrences.
✔ Comprehensive Insights: Assess multiple biomarkers to understand the full scope of the disease.
What Can Liquid Biopsies Detect?
Cancer Detection
- Identifies specific cancer biomarkers for early diagnosis.
- Suitable for detecting breast, lung, colorectal, and other types of cancer.
Cancer Progression Monitoring
- Tracks tumor mutations and treatment response.
- Helps adjust therapies for better outcomes.
Minimal Residual Disease (MRD)
- Detects remaining cancer cells after treatment to prevent relapse.
Genetic Analysis
- Provides information about mutations and biomarkers for personalized treatment options.
Who Should Consider a Liquid Biopsy?
- Individuals with a family history of cancer.
- Patients already diagnosed with cancer for treatment monitoring.
- People seeking early detection for preventive health care.
- Explore our Tumor Marker Tests.
How the Process Works
- Book an Appointment: Schedule your liquid biopsy test.
- Sample Collection: A quick and painless blood draw at our center.
- Analysis: Our advanced laboratory analyzes your sample for cancer biomarkers.
- Consultation: Receive personalized recommendations from our specialists.
Benefits of Liquid Biopsy
✔ Provides real-time insights into your health condition.
✔ Reduces the need for invasive procedures.
✔ Offers actionable data for personalized treatment planning.